Interleukin-15 modulates interferon-γ and β-chemokine production in patients with HIV infection: implications for immune-based therapy

[1]  A. Telenti,et al.  CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. , 2003, Archives of internal medicine.

[2]  J. Altman,et al.  IL-15 enhances survival and function of HIV-specific CD8+ T cells. , 2003, Blood.

[3]  C. Chougnet,et al.  The role of antigen-presenting cells in HIV pathogenesis , 2002, Current infectious disease reports.

[4]  G. d’Ettorre,et al.  Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and -treated patients , 2002, AIDS.

[5]  D. Nickle,et al.  Evidence for Human Immunodeficiency Virus Type 1 Replication In Vivo in CD14+ Monocytes and Its Potential Role as a Source of Virus in Patients on Highly Active Antiretroviral Therapy , 2002, Journal of Virology.

[6]  G. d’Ettorre,et al.  Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection. , 2000, Blood.

[7]  S. Crowe,et al.  HIV‐1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication , 2000, Journal of leukocyte biology.

[8]  M. Lederman,et al.  Immune restoration with antiretroviral therapies: implications for clinical management. , 2000, JAMA.

[9]  K. Rosenthal,et al.  RANTES production by T cells and CD8-mediated inhibition of human immunodeficiency virus gene expression before initiation of potent antiretroviral therapy predict sustained suppression of viral replication. , 2000, The Journal of infectious diseases.

[10]  T. Waldmann,et al.  IL-15 induces the expression of chemokines and their receptors in T lymphocytes. , 1999, Journal of immunology.

[11]  J. Moore,et al.  The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses. , 1999, The Journal of infectious diseases.

[12]  A. Fauci,et al.  Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. , 1998, The Journal of clinical investigation.

[13]  H von Briesen,et al.  Individual cell analysis of the cytokine repertoire in human immunodeficiency virus-1-infected monocytes/macrophages by a combination of immunocytochemistry and in situ hybridization. , 1998, Blood.

[14]  E A Emini,et al.  Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. , 1997, The New England journal of medicine.

[15]  J. Levy,et al.  Do beta-chemokines have clinical relevance in HIV infection? , 1997, The Journal of clinical investigation.

[16]  I. Frank,et al.  IL-15 enhances immune functions during HIV infection. , 1997, Journal of immunology.

[17]  E. R. Stiehm,et al.  Human immunodeficiency virus (HIV) type-1 GP120-specific cell-mediated cytotoxicity (CMC) and natural killer (NK) activity in HIV-infected (HIV+) subjects: enhancement with interleukin-2(IL-2), IL-12, and IL-15. , 1997, Clinical immunology and immunopathology.

[18]  N. Letvin,et al.  IL-15 stimulates the expansion of AIDS virus-specific CTL. , 1996, Journal of immunology.

[19]  I P Keet,et al.  Single cell analysis of IL-4 and IFN-gamma production by T cells from HIV-infected individuals: decreased IFN-gamma in the presence of preserved IL-4 production. , 1996, Journal of immunology.

[20]  M. Lederman,et al.  Activation of antigen-induced lymphocyte proliferation by interleukin-15 without the mitogenic effect of interleukin-2 that may induce human immunodeficiency virus-1 expression. , 1996, The Journal of clinical investigation.

[21]  S. Arya,et al.  Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.

[22]  J. Berzofsky,et al.  Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15 , 1995, The Journal of experimental medicine.

[23]  R. Dubose,et al.  Identification and cloning of a novel IL‐15 binding protein that is structurally related to the alpha chain of the IL‐2 receptor. , 1995, The EMBO journal.

[24]  D. Cosman,et al.  Utilization of the beta and gamma chains of the IL‐2 receptor by the novel cytokine IL‐15. , 1994, The EMBO journal.

[25]  A. Lazzarin,et al.  TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV‐infected patients , 1994, AIDS.

[26]  V. Fung,et al.  Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. , 1994, Science.

[27]  K. D. Jakobsen,et al.  HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway. , 1989, Journal of immunology.

[28]  M. Caligiuri,et al.  Interleukin 15: biology and relevance to human disease. , 2001, Blood.

[29]  Lane Hc,et al.  Cytokine-based therapies for HIV infection. , 2001 .

[30]  T. Waldmann,et al.  The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. , 1999, Annual review of immunology.